| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| RITONAVIR
| RITONAVIR |
ANTIINFECTIVES | ORAL | Cmax 15.5 MICROMOLAR Tmax 3 HOUR VD 26.6 LITER (65 KILOGRAM) PPB 98.5 PERCENT Cl 8.8 LITER / HOUR HT 4 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | HIV PROTEASE PDB 1N49 (VIABILITY OF A DRUG-RESISTANT HIV-1 PROTEASE VARIANT: STRUCTURAL INSIGHTS FOR BETTER ANTI-VIRAL THERAPY) LIGAND CODE = RIT (link to the list of PDB complexes) Download experimental 3D coordinates of RIT with added hydrogens | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE INHIBITOR CHEMBL243 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE Q72874 POL POLYPROTEIN HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME PROTEASE ASPARTIC AA A2A | EMA | |||
